All branded drugs not facing generic, biosimilar competition must abide by MFN order in 'all markets,' HHS tells pharma
President Donald Trump's recent Executive Order on drug prices applies to "all brand products across all markets that do not currently have generic or biosimilar competition," the HHS said in a Tuesday press release.
President Donald Trump's recent Executive Order on drug prices applies to "all brand products across all markets that do not currently have generic or biosimilar competition," the HHS said in a Tuesday press release.
